Amended Statement of Ownership (sc 13g/a)
February 01 2017 - 6:05AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13G/A
Under
the Securities Exchange Act of 1934
(Amendment No. 1)*
Plandai Biotechnology,
Inc.
(Name
of Issuer)
Common Stock
$0.0001 par value
(Title
of Class of Securities)
72703D100
(CUSIP
Number)
December 31, 2016
(Date
of Event which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
o
Rule 13d-1(b)
x
Rule 13d-1(c)
o
Rule 13d-1(d)
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in
a prior cover page.
The information
required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
CUSIP No. 72703D100
|
|
13G/A
|
|
Page 2 of 5 Pages
|
|
|
|
|
|
1.
|
|
NAMES
OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
EMA Financial, LLC
|
|
|
2.
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)
o
(b)
o
|
|
|
3.
|
|
SEC
USE ONLY
|
|
|
4.
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
|
5.
|
|
SOLE
VOTING POWER
20,495,663
|
|
6.
|
|
SHARED
VOTING POWER
0
|
|
7.
|
|
SOLE
DISPOSITIVE POWER
20,495,663
|
|
8.
|
|
SHARED
DISPOSITIVE POWER
0
|
|
|
|
|
|
9.
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,495,663
|
|
|
10.
|
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions)
o
|
|
|
11.
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.9%
|
|
|
12.
|
|
TYPE
OF REPORTING PERSON (see instructions)
OO
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No. 72703D100
|
|
13G/A
|
|
Page 3 of 5 Pages
|
Item 4. Ownership.
Provide the
following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item
1.
|
|
|
|
|
|
(a)
|
|
Amount beneficially owned: 20,495,663
* shares of Common
Stock as of December 31, 2016.
|
|
|
|
|
|
|
(b)
|
|
Percent
of class: 9.9%
The Reporting Persons’
beneficial ownership of
20,495,663* shares of Common Stock constitutes
9.9%* of all the outstanding shares of Common Stock, based upon 186,531,236 shares of Common Stock outstanding as of August
17, 2016, as reported by the Issuer in its most recent Quarterly Report.
|
|
|
|
|
|
|
(c)
|
|
Number of shares as to which
the person has:
|
|
|
|
|
|
|
|
|
(i)
|
Sole power to vote or to direct the vote of
20,495,663*.
|
|
|
|
|
|
|
|
|
(ii)
|
Shared power to vote or to direct the vote 0.
|
|
|
|
|
|
|
|
|
(iii)
|
Sole power to dispose or to direct the disposition of
20,495,663*.
|
|
|
|
|
|
|
|
|
(iv)
|
Shared power to dispose or to direct the disposition of 0*.
* EMA Financial, LLC owns
a Convertible Note (“Note”) which is convertible into shares of Common Stock pursuant to the terms of the Note, which
conversions is limited pursuant to the Ownership Limitation (defined below). In accordance with Rule 13d-4 under the Securities
Exchange Act of 1934, as amended, because the number of shares of Common Stock into which the Note is convertible is limited,
pursuant to the terms of such instruments, to that number of shares of Common Stock which would result in the Reporting Persons
having beneficial ownership of 9.9% of the total issued and outstanding shares of Common Stock (the “Ownership Limitation”),
the Reporting Persons disclaim beneficial ownership of any and all shares of Common Stock that would cause any Reporting Person’s
beneficial ownership to exceed the Ownership Limitation.
|
|
|
|
|
|
Instruction
. For computations regarding securities which represent a right to acquire an underlying security
see
§240.13d-3(d)(1).
Item 5. Ownership
of Five Percent or Less of a Class.
If this statement is being filed
to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent
of the class of securities, check the following
o
.
Instruction
. Dissolution
of a group requires a response to this item.
|
|
|
|
|
CUSIP No. 72703D100
|
|
13G/A
|
|
Page 4 of 5 Pages
|
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not
Applicable
Item 7. Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
Not
Applicable
Item 8. Identification
and Classification of Members of the Group.
Not
Applicable.
Item 9. Notice
of Dissolution of Group.
Not
Applicable.
Item 10. Certification.
|
|
|
|
|
(a)
|
|
The following certification
shall be included if the statement is filed pursuant to §240.13d-1(b):
|
|
|
|
|
|
|
|
By signing below I certify that, to the
best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business
and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction
having that purpose or effect.
|
|
|
|
|
|
(b)
|
|
The following certification
shall be included if the statement is filed pursuant to §240.13d-1(c):
|
|
|
|
|
|
|
|
By signing below I certify that, to the
best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or
with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that purpose or effect.
|
|
|
|
|
|
CUSIP No. 72703D100
|
|
13G/A
|
|
Page 5 of 5 Pages
|
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
|
01/31/2017
|
|
Date
|
|
|
|
/s/
Felicia Preston
|
|
Signature
|
|
|
|
Felicia
Preston/Director
|
|
Name/Title
|
Plandai Biotechnology (PK) (USOTC:PLPL)
Historical Stock Chart
From Nov 2024 to Dec 2024
Plandai Biotechnology (PK) (USOTC:PLPL)
Historical Stock Chart
From Dec 2023 to Dec 2024